Alcon Azione

Alcon Attivo totale

Il Attivo Totale di Alcon (ALC.SW) al 8 ago 2026 è 25,67 miliardi USD. L'anno precedente, Attivo Totale era 24,70 miliardi USD — una variazione del 3,91% (superiore).

Attivo totale

25,67 miliardiUSD

YoY

3,91%

Ultimo aggiornamento:

Attivo Totale di Alcon ammonta a 2026 25,67 miliardi USD. Attivo Totale di Alcon ammontava a 2025 24,70 miliardi USD. Diminuisce del 3,91% superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Alcon Analisi delle Azioni

Cosa fa Alcon? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Alcon azioni

Attivo Totale di Alcon è 25,67 miliardi USD nel 2026.

Il Attivo Totale di Alcon è passato da 24,70 miliardi USD a 25,67 miliardi USD, con una variazione del 3,91 %. Il valore è superiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Alcon di Attivo Totale dal 2006, con valori annuali, grafici e analisi dettagliate.

L'attivo totale rappresenta tutto ciò che un'azienda possiede, inclusi denaro, inventario, proprietà e beni immateriali. È una misura fondamentale della dimensione e della base di risorse di un'azienda.

Il USD di Attivo Totale è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il Alcon di Attivo Totale storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — Alcon

Tutte le Metriche Finanziarie — Alcon